Scientists have called for a new drug to be developed that will be able to block a gene that multiplies the risk of breast cancer returning after treatment. The POLQ gene increases the risk of breast cancer returning after treatment by eight times, researchers at the Cancer Research UK/MRC Gray Institute at Oxford University found, and a drug that could block this gene would increase cancer survival. The scientists believe the gene may cause tumour cells to be more aggressive. (source: nursinginpractice.com)
|